Consistent with the idea that AMPK-α1 is a tumour suppressor, loss of both alleles of Prkaa1 in this model markedly accelerated development of B-cell lymphomas, whereas loss of a single allele had an intermediate effect. This evidence concerns the gene PRKAA1 and B-cell non-Hodgkin lymphoma.